Genetic Assessment of Potential Long-Term On-Target Side Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors

Christopher P. Nelson, Florence Y. Lai, Mintu Nath, Shu Ye, Thomas R. Webb, Heribert Schunkert, Nilesh J. Samani (Corresponding Author)

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Genetic Assessment of Potential Long-Term On-Target Side Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences